Helicobacter Pylori and Iron Deficiency: Prevalence of Association and Effect of Therapy
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Iron deficiency anemia (IDA) is a major health problem in children, effecting up to 20% of
young children. Helicobacter pylori (HP) infection is also reported to be prevalent in
children. Several large epidemiologic studies support an association between HP infection and
lower iron stores. Other small studies suggest improvement in anemia following HP treatment.
We assume that the prevalence of HP infection in Israeli children diagnosed with IDA is high
and that that adding therapy for HP in those children will improve the response to iron
deficiency.
Phase:
Phase 4
Details
Lead Sponsor:
Hadassah Medical Organization
Treatments:
Amoxicillin Clarithromycin Iron Metronidazole Omeprazole